Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir

This publication has 20 references indexed in Scilit:

• The Suitability of an in Situ Perfusion Model for Permeability Determinations: Utility for BCS Class I Biowaiver Requests
  Molecular Pharmaceutics, 2006
• Perspectives on the development of acyclic nucleotide analogs as antiviral drugs
  Antiviral Research, 2006
• Acyclic nucleoside phosphonates: a key class of antiviral drugs
  Nature Reviews Drug Discovery, 2005
• Oral Activity of Ether Lipid Ester Prodrugs of Cidofovir against Experimental Human Cytomegalovirus Infection
  The Journal of Infectious Diseases, 2004
• Design and development of oral drugs for the prophylaxis and treatment of smallpox infection
  Trends in Biotechnology, 2004
• Lessons Learned from Marketed and Investigational Prodrugs
  Journal of Medicinal Chemistry, 2004
• Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir
  Antimicrobial Agents and Chemotherapy, 2004
• PHARMACOKINETICS OF SALICYLATE ESTER PRODRUGS OF CYCLIC HPMPC IN DOGS
  Nucleosides, Nucleotides and Nucleic Acids, 2001
• Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects
  Antiviral Research, 1996
• Chemical Aspects of Selective Toxicity
  Nature, 1958